RxSight (RXST) Return on Invested Capital (2021 - 2025)
RxSight (RXST) has disclosed Return on Invested Capital for 5 consecutive years, with 1.98% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Invested Capital fell 196.0% year-over-year to 1.98%, compared with a TTM value of 1.98% through Dec 2025, down 196.0%, and an annual FY2025 reading of 1.96%, down 194.0% over the prior year.
- Return on Invested Capital was 1.98% for Q4 2025 at RxSight, down from 0.05% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 1.13% in Q3 2021 and bottomed at 1.98% in Q4 2025.
- Average Return on Invested Capital over 5 years is 0.25%, with a median of 0.29% recorded in 2024.
- The sharpest move saw Return on Invested Capital increased 29bps in 2024, then tumbled -196bps in 2025.
- Year by year, Return on Invested Capital stood at 0.29% in 2021, then tumbled by -66bps to 0.48% in 2022, then skyrocketed by 35bps to 0.31% in 2023, then surged by 93bps to 0.02% in 2024, then crashed by -9507bps to 1.98% in 2025.
- Business Quant data shows Return on Invested Capital for RXST at 1.98% in Q4 2025, 0.05% in Q3 2025, and 0.04% in Q2 2025.